LNC Stock Analysis: Lincoln National | NYSE

Insurance - Life | NYSE, USA | Market Cap: 8.008m USD | 12M Return: 27.7% | Charts, Fundamentals & Technical Analysis

Life Insurance, Annuities, Group Protection, Retirement Plans
Total Rating 43
Safety 25
Buy Signal -0.70
Insurance - Life
Industry Rotation: +1.7
Market Cap: 8.01B
Avg Turnover: 70.1M
Risk 3d forecast
Volatility35.9%
VaR 5th Pctl6.21%
VaR vs Median4.90%
Reward TTM
Sharpe Ratio0.73
Rel. Str. IBD64.3
Rel. Str. Peer Group16.7
Character TTM
Beta0.904
Beta Downside1.084
Hurst Exponent0.509
Drawdowns 3y
Max DD29.13%
CAGR/Max DD0.72
CAGR/Mean DD2.19
EPS (Earnings per Share) EPS (Earnings per Share) of LNC over the last years for every Quarter: "2021-06": 3.17, "2021-09": 1.62, "2021-12": 1.56, "2022-03": 1.66, "2022-06": 2.23, "2022-09": -10.23, "2022-12": 0.97, "2023-03": 1.52, "2023-06": 2.02, "2023-09": 0.23, "2023-12": 1.45, "2024-03": 0.41, "2024-06": 1.84, "2024-09": 2.06, "2024-12": 1.91, "2025-03": 1.6, "2025-06": 2.36, "2025-09": 2.04, "2025-12": 2.21, "2026-03": 1.66,
Last SUE: 0.16
Qual. Beats: 0
Revenue Revenue of LNC over the last years for every Quarter: 2021-06: 4851, 2021-09: 5210, 2021-12: 4559, 2022-03: 4701, 2022-06: 5579, 2022-09: 4800, 2022-12: 4068, 2023-03: 3833, 2023-06: 2932, 2023-09: 4226, 2023-12: 721, 2024-03: 4113, 2024-06: 4593, 2024-09: 4198, 2024-12: 5084, 2025-03: 4716, 2025-06: 4065, 2025-09: 4591, 2025-12: 4922, 2026-03: 5306,
Rev. CAGR: 15.44%
Rev. Trend: 72.6%
Last SUE: 1.39
Qual. Beats: 1

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Seasonality 10.5 years of data

Jan +2.7% 2
Feb -3.0% 14
Mar -4.8% 41
Apr -1.9% 14
May +0.9% 2
Jun -0.9% 14
Jul +6.7% 41
Aug -4.5% 38
Sep -1.0% 24
Oct +0.1% 8
Nov -0.6% 11
Dec -1.3% 19

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: LNC Lincoln National

Lincoln National Corporation (LNC) is a Philadelphia-area-based (Radnor, PA) insurance and retirement services company that has operated in the U.S. market since 1905. It runs four business segments: Life Insurance (term, universal, indexed universal, and variable universal life products, plus critical illness and long-term care riders), Annuities (variable, fixed, and registered index-linked), Group Protection (employer-sponsored disability, life, dental, vision, accident, and supplemental health products), and Retirement Plan Services (defined contribution plans, group annuities, and plan administration). Products reach customers through a broad intermediary channel that includes brokers, financial advisors, consultants, third-party administrators, and financial institutions. As a mid-cap member of the Life & Health Insurance sub-industry, LNC reflects the typical diversified insurer structure, combining individual life and annuity offerings with employer-driven group benefits and retirement plan administration.

Headlines to Watch Out For
  • Alternative investment losses weigh on book value and capital position
  • RILA annuities sales accelerate as rate-sensitive product demand rises
  • Capital return to shareholders resumes after strategic divestitures and reinsurance deals
Piotroski VR-10 (Strict) 5.0
Net Income: 1.73b TTM > 0 and > 6% of Revenue
FCF/TA: 0.00 > 0.02 and ΔFCF/TA 0.30 > 1.0
NWC/Revenue: -818.9% < 20% (prev 206.4%; Δ -1.03k% < -1%)
CFO/TA 0.00 > 3% & CFO 243.0m > Net Income 1.73b
Net Debt (-38.3b) to EBITDA (2.19b): -17.49 < 3
Current Ratio: 0.05 > 1.5 & < 3
Outstanding Shares: last quarter (196.3m) vs 12m ago 12.76% < -2%
Gross Margin: 34.44% > 18% (prev 28.00%; Δ 6.44% > 0.5%)
Asset Turnover: 4.79% > 50% (prev 4.86%; Δ -0.07% > 0%)
Interest Coverage Ratio: 8.04 > 6 (EBIT TTM 2.04b / Interest Expense TTM 254.0m)
Altman Z'' -2.37
A: -0.38 (Total Current Assets 7.34b - Total Current Liabilities 162b) / Total Assets 406b
B: 0.02 (Retained Earnings 8.09b / Total Assets 406b)
C: 0.01 (EBIT TTM 2.04b / Avg Total Assets 395b)
D: 0.03 (Book Value of Equity 10.2b / Total Liabilities 396b)
Altman-Z'' = -2.37 = D
Beneish M -3.10
DSRI: 0.99 (Receivables 28.9b/28.6b, Revenue 18.9b/18.6b)
GMI: 0.81 (GM 28.00% / 34.44%)
AQI: 1.15 (AQ_t 0.98 / AQ_t-1 0.86)
SGI: 1.02 (Revenue 18.9b / 18.6b)
TATA: 0.00 (NI 1.73b - CFO 243.0m) / TA 406b)
Beneish M = -3.10 (Cap -4..+1) = AA
What is the price of LNC shares?

As of July 21, 2026, the stock is trading at USD 41.61 with a total of 1,002,600 shares traded. Over the past week, the price has changed by +1.86%, over one month by +11.70%, over three months by +13.36% and over the past year by +27.71%.

Current recommended Stop Loss: 39.60 (which is 4.8% or 1.9 ATR below the current price).

Is LNC a buy, sell or hold?

Lincoln National has received a consensus analysts rating of 3.38. Therefore, it is recommended to hold LNC.

  • StrongBuy: 3
  • Buy: 2
  • Hold: 6
  • Sell: 1
  • StrongSell: 1

What are the forecasts/targets for the LNC price?
Analysts Target Price 44.3 6.3%
Lincoln National (LNC) - Fundamental Data Overview as of 18 July 2026
Market Cap USD = 8.01b (8.01b USD * 1.0 USD.USD)
P/E Trailing = 4.5821
P/E Forward = 4.08
P/S = 0.4253
P/B = 0.8489
P/EG = 1.0102
Revenue TTM = 18.9b USD
EBIT TTM = 2.04b USD
EBITDA TTM = 2.19b USD
Long Term Debt = 5.97b USD (from longTermDebt, last quarter)
Short Term Debt = 400.0m USD (from shortTermDebt, last quarter)
Debt = 6.37b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -38.3b USD (calculated: Debt 6.37b - CCE 44.7b)
Enterprise Value = 8.01b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 8.04 (Ebit TTM 2.04b / Interest Expense TTM 254.0m)
EV/FCF = 32.95x (Enterprise Value 8.01b / FCF TTM 243.0m)
FCF Yield = 3.03% (FCF TTM 243.0m / Enterprise Value 8.01b)
FCF Margin = 1.29% (FCF TTM 243.0m / Revenue TTM 18.9b)
Net Margin = 9.14% (Net Income TTM 1.73b / Revenue TTM 18.9b)
Gross Margin = 34.44% ((Revenue TTM 18.9b - Cost of Revenue TTM 12.4b) / Revenue TTM)
Gross Margin QoQ = 62.14% (prev 60.85%)
Tobins Q-Ratio = 0.02 (Enterprise Value 8.01b / Total Assets 406b)
Interest Expense / Debt = 3.99% (Interest Expense 254.0m / Debt 6.37b)
Taxrate = 15.43% (315.0m / 2.04b)
NOPAT = 1.73b (EBIT 2.04b * (1 - 15.43%))
Current Ratio = 0.05 (Total Current Assets 7.34b / Total Current Liabilities 162b)
Debt / Equity = 0.62 (Debt 6.37b / totalStockholderEquity, last quarter 10.2b)
Debt / EBITDA = -17.49 (Net Debt -38.3b / EBITDA 2.19b)
 Debt / FCF = -157.6 (out of range, set to none) (Net Debt -38.3b / FCF TTM 243.0m)
 Total Stockholder Equity = 10.3b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.44% (Net Income 1.73b / Total Assets 406b)
RoE = 16.79% (Net Income TTM 1.73b / Total Stockholder Equity 10.3b)
RoCE = 12.56% (EBIT 2.04b / Capital Employed (Equity 10.3b + L.T.Debt 5.97b))
RoIC = 0.43% (NOPAT 1.73b / Invested Capital 405b)
WACC = 6.60% (E(8.01b)/V(14.4b) * Re(9.16%) + D(6.37b)/V(14.4b) * Rd(3.99%) * (1-Tc(0.15)))
Discount Rate = 9.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 91.27 | Cagr: 6.70%
[DCF] Terminal Value 75.44% ; FCFF base≈243.0m ; Y1≈244.0m ; Y5≈258.5m
[DCF] Fair Price = 221.3 (EV 4.02b - Net Debt -38.3b = Equity 42.3b / Shares 191.2m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.16 | # QB: 0
Revenue Correlation: 72.55 | Revenue CAGR: 15.44% | SUE: 1.39 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.97 | Chg30d=-2.85% | Revisions=-18% | Analysts=13
EPS next Quarter (2026-09-30): EPS=2.01 | Chg30d=-0.03% | Revisions=+30% | Analysts=11
EPS current Year (2026-12-31): EPS=7.67 | Chg30d=-0.70% | Revisions=-15% | GrowthEPS=-6.8% | GrowthRev=+3.1%
EPS next Year (2027-12-31): EPS=8.43 | Chg30d=+1.25% | Revisions=-42% | GrowthEPS=+9.8% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: -16% (up=14, down=20)